6-Bromo-2,4(1H,3H)-quinazolinedione(CAS: 88145-89-5)

6-Bromo-2,4(1H,3H)-quinazolinedione (CAS: 88145-89-5) is subject to various regulatory guidelines including the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), REACH regulations for European countries, and FDA/EPA requirements for product safety and environmental protection. Specific handling, storage, and disposal guidelines should be followed based on local and national regulations.

Yes, there are alternatives to 6-Bromo-2,4(1H,3H)-quinazolinedione (CAS: 88145-89-5) in synthesis. Common alternatives include 2,4(1H,3H)-quinazolinedione itself, its isomers, and other brominated quinazolines. These alternatives can be chosen based on desired properties and reactivity in specific synthetic contexts.

The market and research trends for 6-Bromo-2,4(1H,3H)-quinazolinedione (CAS: 88145-89-5) indicate increasing interest in its use as a key intermediate in pharmaceutical and agrochemical industries, due to its unique biological activity. Research is focusing on its potential in anticancer and antimicrobial applications, leading to higher demand and investment in related fields.

Waste containing 6-Bromo-2,4(1H,3H)-quinazolinedione (CAS: 88145-89-5) should be managed according to local and national hazardous waste regulations. Proper collection, neutralization, and incineration or professional waste disposal methods are recommended. Care should be taken to ensure minimal environmental impact and compliance with environmental protection standards during disposal.